Chester County News and Community Website
WILMINGTON, DE — Quavo, Inc. announced the launch of Aria, an artificial intelligence tool designed to automate and manage dispute resolution processes for financial institutions, the company said.
Quavo Launches AI Tool for Financial Dispute Management Read More
WILMINGTON, DE — Incyte (Nasdaq: INCY) reported 54-week Phase III data showing its experimental drug povorcitinib reduced disease activity in patients with moderate to severe hidradenitis suppurativa, the company announced …
Incyte Drug Shows Reduced COPD-like HS Flares in Phase III Data Read More
WILMINGTON, DE — AstraZeneca (NYSE: AZN) said its experimental drug tozorakimab reduced moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease in two Phase III trials, according to results from …
AstraZeneca Drug Cuts COPD Exacerbations in Phase III Trials Read More
WILMINGTON, DE — Nearly 45% of global C-suite executives plan to establish a legal entity in the United States within the next 12 months, according to a survey released by …
Survey Finds 45% of Global Executives Plan U.S. Expansion Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) announced executive leadership changes, including the appointment of Pablo J. Cagnoni, M.D., as president and global head of research and development, as the company …
Incyte Names Cagnoni President, Announces Leadership Changes Read More
WILMINGTON, DE — Phreesia has been named to Becker’s Healthcare’s Top Places to Work in Healthcare for 2026, marking the company’s second appearance on the list, the company announced.
Phreesia Named to Becker’s 2026 Top Places to Work List Read More
WILMINGTON, DE — CSC announced it has been named a 2026 Global InfoSec Awards winner for certificate lifecycle management, recognizing its work in digital certificate validation and security services.
CSC Wins Certificate Lifecycle Management Award at InfoSec Event Read More
WILMINGTON, DE — Inhibikase Therapeutics Inc. (Nasdaq: IKT) recently granted stock options covering 685,718 shares to five newly hired non-executive employees under its 2026 Inducement Equity Plan, the company announced.
Inhibikase Grants Stock Options to New Employees Under Inducement Plan Read More WILMINGTON, DE — Novartis has agreed to acquire Pikavation Therapeutics, a subsidiary of Synnovation Therapeutics, in a deal valued at up to $3 billion to expand its oncology pipeline, the …
Novartis to Acquire Synnovation Unit in Deal Worth Up to $3 Billion Read More WILMINGTON, DE — Phreesia and Sesame Workshop received the Point of Care Excellence Award for a pediatric health and wellness campaign, the organizations announced following the Point of Care Marketing …
Phreesia, Sesame Workshop Win Award for Pediatric Health Campaign Read More